Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial
Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial is a paper indexed in PICO Portal from OpenAlex.
How many citations does Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial have?
Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial has 140 citations in the OpenAlex counts PICO Portal stores.
When was Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial published?
Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial has 2018 year in the PICO Portal index.
What is the open-access status of Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial?
Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial has closed oa status in the PICO Portal index.
What is the DOI of Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial?
The DOI for Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial is on the source record.
What is the PMID of Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial?
The PMID for Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial is on the source record.
What is the OpenAlex record for Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial?
The OpenAlex for Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial is on the source record.